There’s long been talk of a new wave of biotech mergers and acquisitions activity coming to life. In modest amounts, there has been evidence of that playing out. But that’s not to the extent market participants are accustomed to. That could soon change. Assuming more biotech consolidation activity arrives, it could benefit ETFs like the [...] The post Patent Cliffs Could Spark Wave of Biotech M&A appeared first on ETF Trends .